Peer Reviewed

editorialoffice@confseries.net   +44 7897-071619

Follow Us:

Journal of Targeted Oncology Research

Frequency : Annual (One issue per year)
Manuscript Guidelines Journals Membership
Editorial & Review Timeline
3 - 4 Days Initial Quality Review
20 Days Peer Evaluation Summary
30 - 45 Days Complete Editorial Processing Time

Volume 1, Issue 1 (2026)

Mini Review | J. Target. Oncol. 2026 April 17; 1(1): 1 - 6
Circulating Tumor Cells as Actionable Biomarkers: Integrating Liquid Biopsy into Targeted Oncology
Zahra Azizi1* and Hamed Gerami2
abstractAbstract Circulating Tumor Cells as Actionable Biomarkers: Integrating Liquid Biopsy into Targeted Oncologyhtml pdfPDF

Publication Standards

Structured Peer Review

Expert Reviewer Evaluation

Transparent Review Process

Time-Bound Editorial Workflow

Open Access Publication

Ethical Publishing Standards

Timely Online Publication

Flyer Image

Flyer Image

Journal Highlights

Cancer Biology and Mechanisms Targeted Therapies Immuno-Oncology Biomarkers and Diagnostics Drug Development and Clinical Trials Radiation and Chemotherapy Enhancements Resistance Mechanisms Translational Research Precision and Personalized Medicine Supportive and Palliative Care

Recommended Journals

Journal of Pharma and Drug Innovation Journal of Neuroscience and Clinical Neurology Journal of Targeted Oncology Research Journal of Cardiovascular Care and Research

About Confseries

Confseries is a platform for publishing high-quality research journals across various disciplines. We aim to provide a seamless experience for authors, reviewers, and readers.

Useful Links

Home Submit Manuscript Author Guidelines Terms and Conditions Contact

Contact Information

+44 7897-071619

oncology@confseries.net

support@confseries.com

Quick Links

Submit

Archive

Contact

Editors

Aims

Guidelines

© Copyright All rights reserved by Confseries